Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest EPS Growth Forecast For Next 5 Years

Below are the top drug delivery stocks on the NASDAQ in terms of EPS growth forecast for the next five years.

earnings per share growth forecast for the next five years is 61.00 percent. Alkermes' trailing-twelve-month revenue is $649.80 million.

EPS growth forecast for the next five years is 34.00 percent. Flamel Technologies' trailing-twelve-month gross margin is 77.00 percent.

EPS growth forecast for the next five years is 15.00 percent. Delcath Systems' trailing-twelve-month revenue is $1.20 million.

earnings per share growth forecast for the next five years is 2.50 percent. Petmed Express' trailing-twelve-month ROE is 23.90 percent.